Clinical manifestations of COVID-19 versus other upper respiratory tract infections in pediatric patients

Saudi Med J. 2023 Jan;44(1):74-79. doi: 10.15537/smj.2023.44.1.20220439.

Abstract

Objectives: To explore the differences between COVID-19 and upper respiratory tract infections (URTI) in the pediatric population, emphasizing smell and taste disturbances.

Methods: A case-control study included 468 patients, 234 with COVID-19 (cases) and 234 with URTI (controls) at a tertiary hospital, Riyadh, Saudi Arabia, from 2020-2021. Patients with bacterial URTI, lower tract respiratory infections, and speech or developmental delays were excluded. Statistical analysis was carried out using Statistical Analysis System, 9.2 version. A p-value of ≤0.05 was considered significant.

Results: The male-to-female ratio was almost equal, with a mean age of 9.90±2.34. Multivariable logistic regression analysis showed that a change in taste significantly increases the probability of COVID-19 by 21.98 times. On the other hand, sore throat (81.5%), dyspnea (63.5%), nasal obstruction (72.7%), and otalgia significantly (74.8%) decrease the likelihood of COVID-19.

Conclusion: Taste disturbances increase the probability of COVID-19 infections, whereas sore throat, dyspnea, nasal obstruction, and otalgia increase the likelihood of other URTIs. The described differences might aid physicians in their differential diagnosis and treatment during the pandemic.

Keywords: COVID-19; URTI; children; manifestations; taste.

MeSH terms

  • COVID-19* / epidemiology
  • Case-Control Studies
  • Child
  • Dyspnea
  • Earache
  • Female
  • Humans
  • Male
  • Nasal Obstruction*
  • Pain
  • Pharyngitis*
  • Respiratory Tract Infections* / epidemiology